Prothena

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally change the course of devastating neurological disorders.

Industries

Biotechnology

Headquarters

Dublin 4, Ireland

Stage

Post IPO Equity

Employees

51-200

Links

Org chart

Gene G. Kinney

President & CEO

Collapse

Tran B. Nguyen

COO & CFO

Brandon Smith

Chief Business Officer

Carol D. Karp

Chief Regulatory Officer

Michael J. Malecek

Chief Legal Officer and Company Secretary

Wagner M. Zago

Chief Scientific Officer

Hideki Garren

Chief Medical Officer

Teams

View all

Board of Directors

7 members

CEO and Executive Team

7 members

Leadership Team

7 members

Discover similar companies

Voyager Therapeutics

Cambridge, United States · Post IPO Equity

Flow Robotics

Copenhagen, Denmark

Exicure

Skokie, United States · Post IPO Equity

NMD Pharma

Aarhus, Denmark

AllStripes

San Francisco, United States · Series B

Korro Bio

Cambridge, United States · Series B

Sutro Biopharma

South San Francisco, United States · Post IPO Equity

Illumina

San Diego, United States

MassBio

Cambridge, United States

DBV Technologies

Montrouge, France · Post IPO Equity

F2G

Manchester, United Kingdom · Private Equity

Alkermes

Dublin 4, Ireland · Post IPO Equity

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.